<DOC>
	<DOCNO>NCT02417597</DOCNO>
	<brief_summary>This phase IV clinical study design evaluate safety immunogenicity recombinant Hepatitis E vaccine ( Hecolin® ) , manufacture Xiamen Innovax Biotech CO. , LTD. , healthy volunteer age 65 year age enrollment . The study volunteer receive 3 dos Hecolin® administer intramuscularly accord 0-1-6 month schedule .</brief_summary>
	<brief_title>A Phase Ⅳ Clinical Trial Recombinant Hepatitis E Vaccine ( Escherichia Coli )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis E</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy people age 18 year old day enrollment 2 . Axillary temperature 37.0 ℃ 3 . Blood pressure high 160/100 mmHg ( without medicine ) 4 . Judged healthy eligible vaccination investigator selfreported medical history physical examination . 5 . Able understand study information willing comply study requirement . 6 . Willing participate study sign inform consent form . 1 . Participated clinical trial study period . 2 . Use investigational product nonregistered product ( drug vaccine ) within 30 day precede first dose study vaccine plan use study period . 3 . Received immunosuppressed , immunoregulation therapy corticosteroid systemic therapy 14 day 6 month entry , except local treatment . 4 . Administration immunoglobulin blood product within 3 month precede first dose study vaccine , plan use study period . 5 . Administration inactivate vaccine within 14 day precede first dose study attenuate live vaccine within 21 day precede first dose study . 6 . Had fever ( axillary temperature 38°C ) within 3 day acute illness require systemic antibiotic antiviral treatment within 5 day vaccination . 7 . Immunodeficiency ( HIV carrier ) , primary disease important organ , malignant tumor , .or immune disease ( systemic lupus erythematosus , arthritis pauperum , splenectomy functional asplenia disease might affect immune response ) . 8 . History allergic disease history serious adverse event occur vaccination , i.e. , allergy , urticaria , dyspnea , angioneurotic edema abdominal pain . 9 . Pregnant breastfeed 10 . Allergic history component vaccine . 11 . Other medical , psychological , social occupational factor , accord investigator ' judgment , might affect individual 's ability obey protocol sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>hepatitis E</keyword>
</DOC>